It's How Medicine Should Be®

Physician Profile


call (888) 352-RUSH for help arranging an appointment

Deborah A. Hall, MD, PhD

Patient Feedback
  • Neurology
Board Certification:
  • Neurology
Faculty Rank: Associate Professor
Medical or Graduate Education: Indiana University School of Medicine
Residency: University of Colorado - Internal Medicine
Fellowship: University of Colorado - Movement Disorders
Clinical Expertise:
  • Ataxia
  • Botulinum toxin injections
  • Chorea
  • Corticobasal degeneration
  • Dystonia
  • Movement disorders
  • Movement disorders, fragile X-associated
  • Multiple system atrophy
  • Myoclonus
  • Parkinson's disease
  • Parkinsonism
  • Progressive supranuclear palsy
  • Restless legs syndrome (RLS)
  • Tics
  • Tourette syndrome
  • Tremor
Research Interests:
  • Genetics and movement disorders
  • Fragile X-associated tremor/ataxia syndrome
  • Neuroepidemiology
  • Clinical trials in Parkinson's disease
  • Exercise in movement disorders
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Psychometric properties of the Tinnitus Functional Index (TFI): Assessment in a UK research volunteer population.
    Fackrell K, Hall DA, Barry JG, Hoare DJ
    Hear. Res.
    2015 Sep 27
  2. Costly Signaling Increases Trust, Even Across Religious Affiliations.
    Hall DL, Cohen AB, Meyer KK, Varley AH, Brewer GA
    Psychol Sci
    2015 Sep
  3. Groundwater pesticide levels and the association with Parkinson disease.
    James KA, Hall DA
    Int. J. Toxicol.
    2015 May-Jun
  4. Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England.
    Martinez C, Wallenhorst C, McFerran D, Hall DA
    Ear Hear
    2015 May-Jun
  5. Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).
    O'Keefe JA, Robertson-Dick E, Dunn EJ, Li Y, Deng Y, Fiutko AN, Berry-Kravis E, Hall DA
    2015 Mar 13
  6. Consensus on Hearing Aid Candidature and Fitting for Mild Hearing Loss, With and Without Tinnitus: Delphi Review.
    Sereda M, Hoare DJ, Nicholson R, Smith S, Hall DA
    Ear Hear
    2015 Jul-Aug
  7. Gait and Functional Mobility Deficits in Fragile X-Associated Tremor/Ataxia Syndrome.
    O'Keefe JA, Robertson-Dick EE, Hall DA, Berry-Kravis E
    2015 Aug 23
  8. Relationship between tinnitus pitch and edge of hearing loss in individuals with a narrow tinnitus bandwidth.
    Sereda M, Edmondson-Jones M, Hall DA
    Int J Audiol
    2015 Apr
  9. Source space estimation of oscillatory power and brain connectivity in tinnitus.
    Zobay O, Palmer AR, Hall DA, Sereda M, Adjamian P
    PLoS ONE
  10. Erratum: Emerging topics in FXTAS.
    Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe JA, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA
    J Neurodev Disord
  11. Toward a Global Consensus on Outcome Measures for Clinical Trials in Tinnitus: Report From the First International Meeting of the COMiT Initiative, November 14, 2014, Amsterdam, The Netherlands.
    Hall DA, Haider H, Kikidis D, Mielczarek M, Mazurek B, Szczepek AJ, Cederroth CR
    Trends Hear
  12. Subtyping Somatic Tinnitus: A Cross-Sectional UK Cohort Study of Demographic, Clinical and Audiological Characteristics.
    Ward J, Vella C, Hoare DJ, Hall DA
    PLoS ONE
  13. Neuroanatomical abnormalities in chronic tinnitus in the human brain.
    Adjamian P, Hall DA, Palmer AR, Allan TW, Langers DR
    Neurosci Biobehav Rev
    2014 Sep
  14. Neuroimaging paradigms for tonotopic mapping (II): the influence of acquisition protocol.
    Langers DR, Sanchez-Panchuelo RM, Francis ST, Krumbholz K, Hall DA
    2014 Oct 15
  15. Neuroimaging paradigms for tonotopic mapping (I): the influence of sound stimulus type.
    Langers DR, Krumbholz K, Bowtell RW, Hall DA
    2014 Oct 15
  16. Fragile X gene expansions are not associated with dementia.
    Hall DA, Bennett DA, Filley CM, Shah RC, Kluger B, Ouyang B, Berry-Kravis E
    Neurobiol. Aging
    2014 May 2
  17. Pitch coding and pitch processing in the human brain.
    Plack CJ, Barker D, Hall DA
    Hear. Res.
    2014 Jan
  18. Special issue in Hearing Research: human auditory neuroimaging.
    Hall DA, Langers DR
    Hear. Res.
    2014 Jan
  19. Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome.
    O'Keefe JA, Espinoza Orías AA, Khan H, Hall DA, Berry-Kravis E, Wimmer MA
    Gait Posture
    2014 Feb
  20. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.
    Niu YQ, Yang JC, Hall DA, Leehey MA, Tassone F, Olichney JM, Hagerman RJ, Zhang L
    Parkinsonism Relat. Disord.
    2014 Apr
  21. Emerging topics in FXTAS.
    Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA
    J Neurodev Disord
  22. New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype.
    Fraint A, Vittal P, Szewka A, Bernard B, Berry-Kravis E, Hall DA
    Front Genet
  23. Gameplay as a source of intrinsic motivation in a randomized controlled trial of auditory training for tinnitus.
    Hoare DJ, Van Labeke N, McCormack A, Sereda M, Smith S, Al Taher H, Kowalkowski VL, Sharples M, Hall DA
    PLoS ONE
  24. A scientific cognitive-behavioral model of tinnitus: novel conceptualizations of tinnitus distress.
    McKenna L, Handscomb L, Hoare DJ, Hall DA
    Front Neurol
  25. In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions?
    Hall DA
    Tremor Other Hyperkinet Mov (N Y)
  26. Agreement and reliability of tinnitus loudness matching and pitch likeness rating.
    Hoare DJ, Edmondson-Jones M, Gander PE, Hall DA
    PLoS ONE
  27. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss.
    Hoare DJ, Edmondson-Jones M, Sereda M, Akeroyd MA, Hall D
    Cochrane Database Syst Rev
  28. Tinnitus.
    Baguley D, McFerran D, Hall D
    2013 Nov 9
  29. Clinical neurogenetics: fragile x-associated tremor/ataxia syndrome.
    Hall DA, O'Keefe JA
    Neurol Clin
    2013 Nov
  30. Intranuclear inclusions in a fragile X mosaic male.
    Pretto DI, Hunsaker MR, Cunningham CL, Greco CM, Hagerman RJ, Noctor SC, Hall DA, Hagerman PJ, Tassone F.
    Transl Neurodegener. 2013
    2013 May 21
    2(1):10. doi: 10.1186/2047-9158-2-10.
  31. Recent technological advances in sound-based approaches to tinnitus treatment: a review of efficacy considered against putative physiological mechanisms.
    Hoare DJ, Adjamian P, Sereda M, Hall DA
    Noise Health
    2013 Mar-Apr
  32. Study in Parkinson Disease of Exercise (SPARX): Translating high-intensity exercise from animals to humans.
    Moore CG, Schenkman M, Kohrt WM, Delitto A, Hall DA, Corcos D.
    Contemp Clin Trials. 2013
    2013 Jun 14
    36(1):90-98. doi: 10.1016/j.cct.2013.06.002. [Epub ahead of print]
  33. Auditory evoked magnetic fields in individuals with tinnitus.
    Sereda M, Adjamian P, Edmondson-Jones M, Palmer AR, Hall DA
    Hear. Res.
    2013 Aug
  34. Investigation of cortical and subcortical plasticity following short-term unilateral auditory deprivation in normal hearing adults.
    Maslin MR, Munro KJ, Lim VK, Purdy SC, Hall DA
    2013 Apr 17
  35. Representations of pitch and slow modulation in auditory cortex.
    Barker D, Plack CJ, Hall DA
    Front Syst Neurosci
  36. Evaluation of the acoustic coordinated reset (CR®) neuromodulation therapy for tinnitus: study protocol for a double-blind randomized placebo-controlled trial.
    Hoare DJ, Pierzycki RH, Thomas H, McAlpine D, Hall DA
  37. A controlled approach to the emotional dilution of the Stroop effect.
    Fackrell K, Edmondson-Jones M, Hall DA
    PLoS ONE
  38. Mapping pitch representation in neural ensembles with fMRI.
    Griffiths TD, Hall DA
    J. Neurosci.
    2012 Sep 26
  39. Neuromagnetic indicators of tinnitus and tinnitus masking in patients with and without hearing loss.
    Adjamian P, Sereda M, Zobay O, Hall DA, Palmer AR
    J. Assoc. Res. Otolaryngol.
    2012 Oct
  40. Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial.
    Schenkman M, Hall DA, Barón AE, Schwartz RS, Mettler P, Kohrt WM.
    Phys Ther. 2012
    2012 Nov
    92(11):1395-410. doi: 10.2522/ptj.20110472. Epub 2012 Jul 19.
  41. Concept to reality: integrating technology in the hospital setting.
    Gwiazdowski A, Hall DE
    Biomed Instrum Technol
    2012 May-Jun
  42. Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.
    Hall D, Tassone F, Klepitskaya O, Leehey M.
    Mov Disord. 2012
    2012 Feb
    27(2):296-300. doi: 10.1002/mds.24021. Epub 2011 Dec 11.
  43. How challenges in auditory fMRI led to general advancements for the field.
    Talavage TM, Hall DA
    2012 Aug 15
  44. Effects of frequency discrimination training on tinnitus: results from two randomised controlled trials.
    Hoare DJ, Kowalkowski VL, Hall DA
    J. Assoc. Res. Otolaryngol.
    2012 Aug
  45. Reexamining the evidence for a pitch-sensitive region: a human fMRI study using iterated ripple noise.
    Barker D, Plack CJ, Hall DA
    Cereb. Cortex
    2012 Apr
  46. Management of tinnitus in English NHS audiology departments: an evaluation of current practice.
    Hoare DJ, Gander PE, Collins L, Smith S, Hall DA
    J Eval Clin Pract
    2012 Apr
  47. Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment.
    Hall DA, O'keefe JA.
    Tremor Other Hyperkinet Mov (N Y). 2012
    2. doi:pii: tre-02-56-352-1. Epub 2012 May 11.
  48. An evaluation of the content and quality of tinnitus information on websites preferred by General Practitioners.
    Fackrell K, Hoare DJ, Smith S, McCormack A, Hall DA
    BMC Med Inform Decis Mak
  49. Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease.
    Schenkman M, Ellis T, Christiansen C, Barón AE, Tickle-Degnen L, Hall DA, Wagenaar R
    Phys Ther
    2011 Sep
  50. Re-examining the relationship between audiometric profile and tinnitus pitch.
    Sereda M, Hall DA, Bosnyak DJ, Edmondson-Jones M, Roberts LE, Adjamian P, Palmer AR
    Int J Audiol
    2011 May
  51. Pragmatic communication is impaired in Parkinson disease.
    Hall D, Ouyang B, Lonnquist E, Newcombe J.
    Int J Neurosci. 2011
    2011 May
    121(5):254-6. doi: 10.3109/00207454.2010.550389. Epub 2011 Feb 25.
  52. Mapping feature-sensitivity and attentional modulation in human auditory cortex with functional magnetic resonance imaging.
    Paltoglou AE, Sumner CJ, Hall DA
    Eur. J. Neurosci.
    2011 May
  53. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management.
    Hoare DJ, Kowalkowski VL, Kang S, Hall DA
    2011 Jul
  54. Human auditory cortical responses to pitch and to pitch strength.
    Barker D, Plack CJ, Hall DA
    2011 Feb 16
  55. Listening to urban soundscapes: Physiological validity of perceptual dimensions.
    Irwin A, Hall DA, Peters A, Plack CJ
    2011 Feb
  56. Clinical guidelines and practice: a commentary on the complexity of tinnitus management.
    Hoare DJ, Hall DA
    Eval Health Prof
    2011 Dec
  57. Executive dysfunction in young FMR1 premutation carriers: forme fruste of FXTAS or new phenotype?
    Berry-Kravis E, Hall DA.
    Neurology. 2011
    2011 Aug 16
    77(7):612-3. doi: 10.1212/WNL.0b013e3182299f98. Epub 2011 Jul 20. No abstract available.
  58. FMR1 gray-zone alleles: association with Parkinson's disease in women?
    Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MA.
    Mov Disord. 2011
    2011 Aug 15
    26(10):1900-6. doi: 10.1002/mds.23755. Epub 2011 May 12.
  59. Primary care for tinnitus: practice and opinion among GPs in England.
    El-Shunnar SK, Hoare DJ, Smith S, Gander PE, Kang S, Fackrell K, Hall DA
    J Eval Clin Pract
    2011 Aug
  60. Transmission stages dominate trypanosome within-host dynamics during chronic infections.
    MacGregor P, Savill NJ, Hall D, Matthews KR
    Cell Host Microbe
    2011 Apr 21
  61. Reducing the effects of background noise during auditory functional magnetic resonance imaging of speech processing: qualitative and quantitative comparisons between two image acquisition schemes and noise cancellation.
    Blackman GA, Hall DA
    J. Speech Lang. Hear. Res.
    2011 Apr
  62. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA.
    Hall DA, Láinez MJ, Newman CW, Sanchez TG, Egler M, Tennigkeit F, Koch M, Langguth B
    BMC Health Serv Res
  63. Tinnitus referral pathways within the National Health Service in England: a survey of their perceived effectiveness among audiology staff.
    Gander PE, Hoare DJ, Collins L, Smith S, Hall DA
    BMC Health Serv Res
  64. Spatially extended FMRI signal response to stimulus in non-functionally relevant regions of the human brain: preliminary results.
    Kornak J, Hall DA, Haggard MP
    Open Neuroimag J
  65. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine.
    Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJ.
    J Clin Psychopharmacol. 2010
    2010 Oct
    30(5):642-4. doi: 10.1097/JCP.0b013e3181f1d10a. No abstract available.
  66. Shoulder pain in Parkinson's disease: a case-control study.
    Madden MB, Hall DA.
    Mov Disord. 2010
    2010 Jun 15
    25(8):1105-6. doi: 10.1002/mds.23048. No abstract available.
  67. Parkinsonism and cognitive decline in a fragile X mosaic male.
    Hall D, Pickler L, Riley K, Tassone F, Hagerman R.
    Mov Disord. 2010
    2010 Jul 30
    25(10):1523-4. doi: 10.1002/mds.23150. No abstract available.
  68. The efficacy of auditory perceptual training for tinnitus: a systematic review.
    Hoare DJ, Stacey PC, Hall DA
    Ann Behav Med
    2010 Dec
  69. Tremor in 48,XXYY syndrome.
    Tartaglia N, Borodyanskaya M, Hall DA.
    Mov Disord. 2009
    2009 Oct 15
    24(13):2001-7. doi: 10.1002/mds.22700. Erratum in: Mov Disord. 2010 Aug 15;25(11):1764. Borodyanskya, Mariya [corrected to Borodyanskaya, Mariya].
  70. Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.
    Hall DA, Howard K, Hagerman R, Leehey MA.
    Parkinsonism Relat Disord. 2009
    2009 Feb
    15(2):156-9. doi: 10.1016/j.parkreldis.2008.04.037. Epub 2008 Jun 20.
  71. Movement disorders associated with aripiprazole use: a case series.
    Hall DA, Agarwal P, Griffith A, Segro V, Seeberger LC.
    Int J Neurosci. 2009
    119(12):2274-9. doi: 10.3109/00207450903225553.
  72. Persistent neurobehavioral signs and symptoms following West Nile fever.
    Hall DA, Tyler KL, Frey KL, Kozora E, Arciniegas DB.
    J Neuropsychiatry Clin Neurosci.
    2008 Winter
  73. Endurance exercise training to improve economy of movement of people with Parkinson disease: three case reports.
    Schenkman M, Hall D, Kumar R, Kohrt WM.
    Phys Ther.
    2008 Jan
  74. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome.
    Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A.
    2008 Jan
  75. Adult-onset Alexander disease with progressive ataxia and palatal tremor.
    Howard KL, Hall DA, Moon M, Agarwal P, Newman E, Brenner M.
    Mov Disord.
    2008 Jan
  76. Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
    Hagerman RJ, Hall DA, Coffey S, Leehey M, Bourgeois J, Gould J, Zhang L, Seritan A, Berry-Kravis E, Olichney J, Miller JW, Fong AL, Carpenter R, Bodine C, Gane LW, Rainin E, Hagerman H, Hagerman PJ
    Clin Interv Aging
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript
Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.